InflaRx to prioritize izicopan as its leading pipeline asset, with a goal of continuing toward Phase 2b readiness in hidradenitis suppurativa ...
VANCOUVER, BC / ACCESS Newswire / January 8, 2026 / LIR Life Sciences Corp. (WKN: A41QA9) ("LIR" or the "Company") is pleased to announce that it has entered into a services agreement (" ...
Researchers at UC San Francisco have devised a method to identify pneumonia — using both genetic information and AI — that ...
Bamboo tissue has become a staple of eco aisles, marketed as a quick swap that lets shoppers keep their habits while cutting ...